cefixime has been researched along with Pneumonia, Pneumococcal in 5 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Pneumonia, Pneumococcal: A febrile disease caused by STREPTOCOCCUS PNEUMONIAE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The antibiotic was given at a dosage of 200 mg b." | 6.67 | [Clinical experiences with cefixime in the treatment of bacterial infections of the lower respiratory tract]. ( Kersten, W; Müsken, H, 1990) |
| "The therapeutic activity of FCE 22891 was compared with that of two new oral cephalosporins, cefuroxime axetil and cefixime against Streptococcus pneumoniae respiratory infection and subcutaneous abscesses induced by mixed aerobes and anaerobes in mice." | 3.67 | Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice. ( Castellani, P; Della Bruna, C; Rossi, R; Younes, G, 1989) |
| "This study compared the efficacy and tolerability of once-daily dosing with either roxithromycin or cefixime in previously healthy adult patients aged between 18 and 60 with markers of uncomplicated community-acquired pneumonia (CAP) in three outpatient clinics in an open, randomized study." | 2.69 | Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia. ( Fachinelli, H; Kijanczuk, S; Mingrone, H; Salvarezza, CR, 1998) |
| " The antibiotic was given at a dosage of 200 mg b." | 2.67 | [Clinical experiences with cefixime in the treatment of bacterial infections of the lower respiratory tract]. ( Kersten, W; Müsken, H, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amir, J | 1 |
| Harel, L | 1 |
| Eidlitz-Markus, T | 1 |
| Varsano, I | 1 |
| Salvarezza, CR | 1 |
| Mingrone, H | 1 |
| Fachinelli, H | 1 |
| Kijanczuk, S | 1 |
| Calvo, A | 1 |
| Amores, R | 1 |
| Valero, E | 1 |
| Sevillano, D | 1 |
| Prieto, J | 1 |
| Kersten, W | 1 |
| Müsken, H | 1 |
| Rossi, R | 1 |
| Castellani, P | 1 |
| Younes, G | 1 |
| Della Bruna, C | 1 |
3 trials available for cefixime and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
Comparative evaluation of cefixime versus amoxicillin-clavulanate following ceftriaxone therapy of pneumonia.
Topics: Administration, Oral; Amoxicillin; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child, Prescho | 1996 |
Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Community-Acquired I | 1998 |
[Clinical experiences with cefixime in the treatment of bacterial infections of the lower respiratory tract].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Bronchopneu | 1990 |
2 other studies available for cefixime and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefixime; Cefpodoxime; Ceftibuten; Cefti | 2001 |
Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Inf | 1989 |